Public attention focused on early detection and strategies to prevent breast cancer.

A new blood-based genetic test might predict the presence of dangerous BRCA1 or BRCA2 gene mutations in women, according to a study published in the January 22 issue of Cancer Prevention Research.

Atossa Genetics develops noninvasive method of nipple aspirate fluid collection for cytological testing.

Atossa Genetics developing diagnostic and therapeutic system in effort to curb trend.